PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2025 Earnings Call Transcript February 20, 2026
Operator: Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] Today’s conference is being recorded. I would now like to turn the conference over to Ellen Cavaleri, Head of Investor Relations. Please go ahead.
Ellen Cavaleri: Good afternoon, and thank you for joining us to discuss PTC Therapeutics’...
